Abstract
concentrations of both compounds (51) , whereas weekly or longer interval dosing will result in large fluctuations in circulating vitamin D but stable concentrations of 25(OH)D (77) (78) (79) . Indeed, any highdose, long-interval dosing schedule can be considered pharmacological rather than physiological. The clearest example of this occurs during human lactation. Our laboratory has been involved in this area of investigation during the last three decades. We published the first comprehensive report that quantified vitamin D and its various metabolites in human milk (80) and remain active in this area of work. Our interest in this area was sparked during undergraduate training (B.W.H.) when human milk was described as the perfect food for the newborn infant, except that it was deficient in vitamin D and breastfeeding could result in rickets to the nursing infant. Sadly, this fact is still true today in that the solely breastfed infant can exhibit severe vitamin D deficiency (81) . For dieticians, nutritionists, and primary medical practitioners, the solution was simple-provide supplemental vitamin D drops for the nursing infant and the problem will be solved (82) . But why should this problem exist, and how was it avoided in early humans?
Biological Roles in Human Physiology
Our initial work on the vitamin D content of human milk showed it to be woefully inadequate in vitamin D, confirming earlier work using bioassay methodology (83) . In hindsight, this error was easy to make because only 25(OH)D was assayed and detected in human milk, and the parent vitamin D could not be measured due to inadequate methodology (80, 84) . The basic problem, though, was that there was little circulating vitamin D in the mothers because they had poor oral intake and little UV exposure. Thus, were indeed safe (55, 56) . We utilized the findings of the 1999 Vieth study (89) to gain Institutional Review Board approval for a series of studies that clearly demonstrated our hypothesis (53, 90, 91) . In addition, in our initial pilot studies, we found that maternal adherence (compliance) with vitamin D supplementation exceeded 90%, whereas adherence rates for giving infant vitamin D drops was only 70% (53, 90) -data that allowed us to proceed to a National Institute of Child Health and Human Development 6-year, two-site, double-blind, randomized controlled trial (RCT) that fully confirmed our initial observation (91). 
Dosing of Vitamin D and How It May Affect Study Outcomes
In 2010, the IOM committee on vitamin D suggested that the only data useful for advising changes in policy would have to originate from RCTs (92); however, RCTs are extremely expensive, and for vitamin D compounds, there is no financial incentive for their use. Furthermore, designing RCTs for nutrients is more challenging than for new medications because nutrients are normally taken in the diet, and for vitamin D, it is provided by diet as well as sunlight, confounding RCT data (104) . Thus, we tend to see small trials performed on specific topics or in specific diseases (23-27, 64-76) or at certain times in the lifecycle, such as pregnancy (51, 62, 105) and lactation (53, 90, 106) .
Infection
In addition to vitamin D trials for skeletal outcomes, the role of vitamin D in infectious disease currently is a hot topic of investigation (15-22, 63, 107, 108) . Treatment/prevention of infectious disease with vitamin D must depend on its autocrine roles. Three high-profile negative studies recently have been reported (15, 22, 63 
